Promises and forecasts attributed to Celltrion in news reports, sealed when reported. A record shows what was reported as said, with the original link; it is not a judgement of the person.
Celltrion said Thursday it will present clinical data on its autoimmune disease treatment Remsima SC and promote its broader inflammatory bowel disease (IBD) drug portfolio at UEG Week 2026 in Barcelona, Spain, from Saturday to Tuesday.
OPEN · DUE 13 APR 2027said 15 Oct 2026Promiserecord →